← Back to headlines
Novo Nordisk to Cut U.S. Prices for Ozempic and Wegovy
Novo Nordisk announced plans to reduce the U.S. list prices for its popular diabetes and weight-loss drugs, Ozempic and Wegovy, by up to 50%.
24 Feb, 19:19 — 24 Feb, 19:19
Sources
Showing 1 of 1 sources
Related Stories
West Nile Fever Cases and Fatalities Reported in Serbia and North Macedonia
51m ago
Five Teenagers Die in Ireland Driving Wrong Way on Motorway for Social Media Trend
1h ago
Hayden Panettiere's Death at 36 Under Investigation
1h ago
Nikšić Children's Dispensary Undergoing Adaptation, Services Relocated
2h ago